Wegovy age limit: who qualifies and why it matters

Why is Wegovy not approved for under-18s in the UK?

The short answer is that the clinical evidence doesn't yet support it. The UK marketing authorisation for Wegovy specifically covers adults, meaning people aged 18 and above. The large STEP 1 trial that underpinned the MHRA's approval enrolled adults, so there is no robust randomised trial data for younger people using the 2.4mg dose for weight management. This isn't a technicality, regulators use age thresholds precisely because metabolism, growth patterns and hormonal profiles differ enough in adolescents that adult trial data cannot simply be extrapolated.

It also means no licensed prescriber in the UK can lawfully prescribe Wegovy for weight management in a person under 18, regardless of how high their BMI is or what conditions they have. If a young person or their family is concerned about weight as a health issue, their GP is the right starting point. That conversation belongs in a paediatric or specialist setting.

The semaglutide age limit for the injection is therefore a firm lower bound, not a sliding scale. Families sometimes come to us having seen US coverage of adolescent obesity trials, those are a different regulatory jurisdiction and a different approved indication. The Wegovy age guidance page sets out the UK position clearly if you want to read further.

Is there a maximum age at which Wegovy becomes unsuitable?

No upper age limit appears in the UK licence. A healthy 72-year-old with obesity and high blood pressure is not automatically disqualified. What changes with age is the clinical complexity around the prescription.

Older adults are more likely to be taking multiple medicines, which raises the question of interactions. Wegovy slows gastric emptying, and that can affect how quickly other oral medicines are absorbed. A prescriber needs to review the full medicines list. Kidney function also tends to decline with age, and because severe nausea, vomiting or diarrhoea from GLP-1 treatment can lead to dehydration, anyone with reduced renal reserve needs careful monitoring. Muscle loss is another consideration: significant calorie reduction alongside an already-reduced muscle mass can compound sarcopenia if protein intake and resistance activity aren't maintained.

None of this rules out Wegovy for older people. It means the assessment is more detailed. Readers thinking through these questions in the context of being older can find a dedicated discussion on the Wegovy and older adults page. For anyone over about 65, the prescriber conversation is probably longer, and that's actually a good sign, it means it's being taken seriously.

How does the semaglutide age limit interact with NHS eligibility?

On the NHS, Wegovy access follows NICE technology appraisal TA875, which recommends semaglutide for adults aged 18 and over with a BMI of 35 or above and at least one weight-related condition, used within a specialist weight management service for a maximum of two years. Age in itself is not a criterion for exclusion under TA875, but the requirement for a specialist service means access is routed through NHS services that have their own clinical intake processes, and waiting lists can be long.

Private prescribing follows the SmPC eligibility: adults, BMI 30 or above (or 27 and above with a qualifying condition). The minimum age remains 18. At a service like nume, a GPhC-registered prescriber reviews the consultation (not software) and that review takes in the whole person, not just the BMI number. The Wegovy age range page breaks down how this works across different life stages, from young adults to retirement age.

One thing worth knowing: the NICE NHS route is subject to commissioning by local integrated care boards, so your local availability may differ from a neighbouring area. Private prescribing doesn't have that postcode variation.

What should people at the edges of the age range do next?

If you're 18 and wondering whether you're old enough, the licence says yes, but your BMI and health picture still determine clinical suitability. Turning 18 this autumn, having a quick online consultation in the morning and having your prescription reviewed by lunchtime is genuinely how this works, so the process itself doesn't drag.

If you're older (60s, 70s) and wondering whether the age ceiling is a problem, it isn't, but the consultation will cover more ground. Bring a list of your current medicines. A prescriber will want to check for anything that could interact with semaglutide's gastric-emptying effect.

The what age can you take Wegovy page addresses some of the more specific age scenarios. For a complete picture of Wegovy as a treatment, including how results compare across doses, the Wegovy treatment guide is a thorough starting point. And if cost context matters to you, the weight-loss treatments overview sets out what private prescribing typically involves.

When you're ready to see whether you're clinically eligible, check your eligibility with a free consultation. A prescriber reads your answers the same day.